The care coordination and communication platform guides patients through their healthcare journeyRead more...
Return investors include Emergence Capital, Rembrandt Venture Partners and Greenhouse Capital
InsideView, a company which provides social media applications to the enterprise, has racked up more cash. The startup announced on Wednesday that it closed $11.5 million in Series B financing. All current investors led the round which include Emergence Capital Partners, Rembrandt Venture Partners and Greenhouse Capital Partners. The San Francisco-based company raised a round of $6.5 million back in January of 2009, and a Series A round of $7.4 million back in 2007.
The company's main offering is a sales productivity tool called SalesView. It basically continuously aggregates and analyzes information from all across the Web to help uncover new sales opportunities. It markets itself as a sales 2.0 application with real-time intelligence which can gather sales information from sites like Thomson Reuters, Jigsaw, Facebook, Twitter, LinkedIn and 20,000 online news sources.
The product is offered for free and also has several upsellable versions including Pro and Team which both have monthly fees. SalesView can also be integrated with SalesForce and is one of the featured apps on the SalesForce AppExchange.
InsideView's CEO, Umberto Milleti commented in a press release, "We have built a strong emerging leadership position in this new Sales 2.0 market, and we see tremendous interest from companies that want to put more power and science behind their sales efforts. We believe that sales, powered by InsideView, is the engine that will drive our customers' growth -- and our mission is to put the right information at the fingertips of salespeople precisely when and where they need it."
The company said it would use the new financing to expand customer acquisition efforts and scale user adoption and customer success, while accelerating the company's investment in product development.
Support VatorNews by Donating
Read more from our "Trends and news" series
September 21, 2021
September 20, 2021
A number of 2021 healthtech companies are trading below their IPO price, with reduced market capsRead more...
September 16, 2021
The company raised $100 million in the initial Series C tranch in AprilRead more...